financetom
Business
financetom
/
Business
/
Primerica Q2 adjusted EPS beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Primerica Q2 adjusted EPS beats estimates
Aug 6, 2025 1:41 PM

Overview

* Primerica ( PRI ) Q2 adjusted rev rises 7%, beating analyst expectations, per LSEG data

* Adjusted EPS for Q2 beats estimates, per LSEG data

* ISP sales up 15%, client asset values reach record $120 bln

Outlook

* Company remains confident in sales force amid economic uncertainty

Result Drivers

* ISP GROWTH - Investment and Savings Products sales rose 15%, with client asset values reaching a record $120 bln

* TERM LIFE PREMIUMS - Term Life adjusted direct premiums increased 5%, supporting a 3% rise in revenues

* SALES FORCE EXPANSION - Life-licensed sales force grew 5% year-over-year, reaching 152,592 representatives

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $796 mln $787.60

Adjusted mln (6

Revenue Analysts

)

Q2 Beat $5.46 $5.21

Adjusted (10

EPS Analysts

)

Q2 EPS $5.4

Q2 Net $178.30

Income mln

Q2 $180.40

Adjusted mln

operatin

g income

Q2 ROE 31.3%

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the life & health insurance peer group is "buy."

* Wall Street's median 12-month price target for Primerica Inc ( PRI ) is $297.00, about 11.1% above its August 5 closing price of $264.05

* The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
High Tide Fiscal Q3 Revenue Rises
High Tide Fiscal Q3 Revenue Rises
Sep 15, 2025
04:22 PM EDT, 09/15/2025 (MT Newswires) -- High Tide (HITI) reported fiscal Q3 earnings late Monday of CA$0.01 ($0.007) per diluted share, the same when compared to a year earlier. Four analysts surveyed by FactSet expected a loss of CA$0.01. Revenue for the quarter ended July 31 was CA$149.7 million, up from CA$131.7 million a year earlier. Analysts polled by...
Urgent-Canada's antitrust regulator to review Anglo-Teck merger
Urgent-Canada's antitrust regulator to review Anglo-Teck merger
Sep 15, 2025
TORONTO, Sept 15 (Reuters) - Canada's antitrust regulator will review the proposed merger of Anglo American with Teck Resources ( TECK ), the regulator said on Monday. I can confirm that the proposed Teck-Anglo merger will be reviewed by the Competition Bureau, Marianne Blondin, senior communications advisor at the competition bureau in Canada said in an emailed statement. (Divya Rajagopal...
Viasat Insider Sold Shares Worth $3,099,900, According to a Recent SEC Filing
Viasat Insider Sold Shares Worth $3,099,900, According to a Recent SEC Filing
Sep 15, 2025
04:18 PM EDT, 09/15/2025 (MT Newswires) -- Richard A Baldridge, Director, on September 11, 2025, sold 100,000 shares in Viasat ( VSAT ) for $3,099,900. Following the Form 4 filing with the SEC, Baldridge has control over a total of 252,161 common shares of the company, with 55,000 shares held directly and 197,161 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/797721/000119312525203563/xslF345X05/ownership.xml ...
Avidity Biosciences Closes $690 Million Share Offering
Avidity Biosciences Closes $690 Million Share Offering
Sep 15, 2025
04:20 PM EDT, 09/15/2025 (MT Newswires) -- Avidity Biosciences ( RNA ) said Monday it closed its underwritten public offering of nearly 17.3 million shares, including about 2.3 million shares sold under the underwriters' full exercise of an option to buy additional shares, at $40 per share, for gross proceeds of $690 million. The company said it intends to use...
Copyright 2023-2026 - www.financetom.com All Rights Reserved